Full-Time

AVP – Strategy Advancement and Decision Quality

Posted on 9/3/2026

Deadline 9/17/26
Humana

Humana

10,001+ employees

Medicare Advantage health insurer for seniors

Compensation Overview

$184.8k - $254.1k/yr

+ Bonus incentive plan

Kentucky, USA

Remote

Category
Business & Strategy (1)
Required Skills
Forecasting

Get referred to Humana

See people who can refer or advise you

Requirements
  • Deep understanding of organizational capabilities, market dynamics, and enterprise strategy.
  • Ability to synthesize complex information into actionable insights.
  • Ability to influence senior leaders and stakeholders without direct authority.
  • Ability to evaluate strategic tradeoffs and support complex enterprise and market-level decisions.
  • Ability to establish and enhance decision-making frameworks, governance mechanisms, and strategic review processes.
Responsibilities
  • Serve as an independent challenge and alignment function to improve the quality, consistency, and effectiveness of enterprise and market-level decision making.
  • Evaluate strategic priorities, assumptions, and growth initiatives to ensure alignment with enterprise objectives and market realities.
  • Advance organizational decision-making capabilities through improved frameworks, governance mechanisms, and decision disciplines.
  • Serve as Secretary of all Bid Decision Forums, maintaining the official record of decisions, assumptions, deliberations, votes, and action items while ensuring adherence to governance standards and established decision-making protocols.
  • Support Bid Decision Forum Chairs in agenda development, decision documentation, issue escalation, and communication of outcomes.
  • Promote rigorous analysis, constructive challenge, accountability, and disciplined decision making across business functions.
  • Act as a trusted advisor to executive leaders on significant strategic, operational, and market-related decisions.
  • Facilitate alignment across Finance, Markets, Provider Strategy, and Growth Strategy on priorities, assumptions, and key decisions.
  • Identify strategic interdependencies, unintended consequences, and areas of organizational misalignment.
  • Support enterprise governance and decision forums by ensuring discussions are informed by objective analysis and strategic context.
  • Drive transparency, consistency, and accountability in strategic decision-making processes.
  • Lead, coach, and develop team members while fostering strategic thinking, collaboration, and continuous improvement.
  • Build partnerships across business functions to advance organizational effectiveness and business outcomes.
  • Represent the function in enterprise governance, bid, and strategic leadership forums.
  • Shape enterprise and market-level decisions through independent challenge, strategic analysis, governance leadership, and cross-functional influence.
  • Recommend changes to assumptions, priorities, strategies, and decision approaches when warranted by analysis or changing market conditions.
  • Escalate significant risks, strategic tradeoffs, and organizational misalignments to executive leadership as appropriate.
  • Serve as an objective voice that strengthens organizational decision quality without owning functional operations, financial planning, forecasting, or reporting.
  • Partner with Finance leadership, Individual Medicare Advantage leadership, Market Presidents and Market Leadership Teams, Growth Strategy leadership, Provider Strategy and Network leaders, Product and Pricing leaders, Enterprise Strategy and Governance leaders, Bid Governance Forums, executive decision-making bodies, and Executive Leadership Team members supporting enterprise strategy and growth.

Humana focuses on health and well-being by offering Medicare Advantage plans (HMO, PPO, and PFFS) mainly for seniors, military personnel, and communities. Its products are health insurance plans funded through a mix of government contracts and member premiums, enrolling members to provide comprehensive coverage with flexible benefits and a broad provider network. Members receive care through a network of providers, with additional services such as free language interpretation to improve accessibility. Humana differentiates itself through its emphasis on inclusivity, accessibility, and tailored benefits, aiming to deliver reliable service and high renewal rates. The goal is to improve health outcomes and overall well-being for members by delivering coverage that meets diverse needs and making care accessible to all.

Company Size

10,001+

Company Stage

IPO

Headquarters

Louisville, Kentucky

Founded

1961

Get referred to Humana

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Second-quarter 2026 revenue reached $40.87 billion, up 26.2%, beating estimates.
  • Illinois awarded Humana a statewide Medicaid contract starting January 2027, broadening state footing.
  • Humana expects 2027 MA membership growth of roughly 25%, despite plan exits.

What critics are saying

  • CMS star-rating losses cut 2026 GAAP EPS guidance to at least $6.52.
  • 2027 plan exits hit 600,000 members, risking churn and weaker brand trust.
  • Texas appeal loss or further CMS downgrades can erase billions in MA bonuses.

What makes Humana unique

  • Humana leads Medicare Advantage with 6.45 million individual MA members in 2026.
  • CenterWell and Medicaid expansion add care delivery and government-contract diversification beyond insurance.
  • August 2026 board adds Anthropic's Paul Smith, signaling faster AI-enabled care operations.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Unlimited Paid Time Off

Paid Vacation

Paid Parental Leave

Short-term Disability

Long-term Disability

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

6%

2 year growth

6%
PR Newswire
Sep 2nd, 2026
Thyme Care raises $125M at $2B+ valuation to expand oncology care model

Thyme Care, a Nashville-based oncology company, has closed a Series E funding round of more than $125 million at a valuation exceeding $2 billion. Morgan Health led the round, with participation from CVS Health Ventures, Humana, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health. The company now serves over 10.5 million people across all 50 US states and manages more than $7 billion in oncology spend. Thyme Care reports it is profitable with positive free cash flow whilst delivering validated reductions of 5 to 10 per cent in total cost of care. Alongside the funding, Thyme Care is establishing Thyme Companies, a parent entity that will build a portfolio of independent oncology businesses addressing care barriers. Co-founder Robin Shah will serve as executive chairman of the new entity.

Associated Press
Aug 20th, 2026
Humana appoints Dr. Shantanu Nundy as chief medical officer to lead AI and digital care strategy

Humana has appointed Dr Shantanu Nundy as Chief Medical Officer, effective 31 August. Dr Nundy, a practicing physician and healthcare executive, will help shape the company's products, platforms, and use of AI whilst bringing clinical expertise to the enterprise. He most recently served as Executive Vice President of Care Delivery and Chief Health Officer at Accolade, a healthcare navigation company. Previously, he was Managing Director for Clinical Innovation at Evolent Health, driving value-based and digital care transformation across health systems. Dr Nundy will report to Jim Rechtin, Humana's President and CEO, and join the company's Enterprise Leadership Team. He continues to practice primary care and hospital medicine.

Yahoo Finance
Aug 19th, 2026
Humana beats Q2 revenue estimates with $40.87B as health insurers face regulatory scrutiny

Humana reported Q2 revenues of $40.87 billion, up 26.2% year on year, exceeding analysts' expectations by 0.6%. The health insurance provider also beat earnings per share estimates. Despite the relatively strong results, Humana's stock has fallen 2.7% since the earnings announcement and currently trades at $378.11. The health insurance sector as a whole showed resilience in Q2, with the 12 tracked providers beating revenue consensus estimates by 2.8% on average. However, share prices across the sector have declined an average of 5.8% since reporting. Humana derives over 80% of its revenue from federal government contracts and serves approximately 17 million members, with a strong focus on Medicare Advantage plans for seniors.

Yahoo Finance
Aug 17th, 2026
Health insurers drop Medicare Advantage plans affecting nearly 3M older Americans

Nearly 3 million older Americans will lose their Medicare Advantage plans this year, according to Johns Hopkins Bloomberg School of Public Health research. One in 10 Medicare Advantage policyholders face forced disenrollment, with Vermont hit hardest at 92% of policyholders affected. Humana announced its exit from multiple markets for the second consecutive year, impacting 600,000 members. The company reported $1.9 billion profit in the first half of 2026. Insurers cite financial pressures from federal policy changes aimed at reducing overpayments, resulting in lower government reimbursement rates. Combined with rising medical costs, these factors are squeezing profit margins. Shannon Benton of Senior Citizens League said Humana's decision shows Medicare Advantage insurers are "prioritising profit growth over enrollment growth.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.

INACTIVE